BAX
Price
$30.39
Change
-$0.11 (-0.36%)
Updated
Jun 27 closing price
Capitalization
21.77B
25 days until earnings call
MTD
Price
$1184.54
Change
-$8.77 (-0.73%)
Updated
Jun 27 closing price
Capitalization
28.69B
24 days until earnings call
Interact to see
Advertisement

BAX vs MTD

Header iconBAX vs MTD Comparison
Open Charts BAX vs MTDBanner chart's image
Baxter International
Price$30.39
Change-$0.11 (-0.36%)
Volume$3.86M
Capitalization21.77B
Mettler-Toledo International
Price$1184.54
Change-$8.77 (-0.73%)
Volume$163.65K
Capitalization28.69B
BAX vs MTD Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. MTD commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Buy and MTD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BAX: $30.39 vs. MTD: $1184.54)
Brand notoriety: BAX and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 107% vs. MTD: 79%
Market capitalization -- BAX: $21.77B vs. MTD: $28.69B
BAX [@Medical Specialties] is valued at $21.77B. MTD’s [@Medical Specialties] market capitalization is $28.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, BAX is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 3 TA indicator(s) are bullish while MTD’s TA Score has 3 bullish TA indicator(s).

  • BAX’s TA Score: 3 bullish, 6 bearish.
  • MTD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MTD is a better buy in the short-term than BAX.

Price Growth

BAX (@Medical Specialties) experienced а +1.33% price change this week, while MTD (@Medical Specialties) price change was +2.65% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.14%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -0.01%.

Reported Earning Dates

BAX is expected to report earnings on Jul 24, 2025.

MTD is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+1.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($28.7B) has a higher market cap than BAX($21.8B). BAX has higher P/E ratio than MTD: BAX (85.61) vs MTD (37.36). BAX YTD gains are higher at: 5.308 vs. MTD (-3.199). BAX has higher annual earnings (EBITDA): 1.67B vs. MTD (1.17B). BAX has more cash in the bank: 3.19B vs. MTD (69.8M). MTD has less debt than BAX: MTD (2.08B) vs BAX (14.4B). BAX has higher revenues than MTD: BAX (14.8B) vs MTD (3.79B).
BAXMTDBAX / MTD
Capitalization21.8B28.7B76%
EBITDA1.67B1.17B143%
Gain YTD5.308-3.199-166%
P/E Ratio85.6137.36229%
Revenue14.8B3.79B391%
Total Cash3.19B69.8M4,576%
Total Debt14.4B2.08B692%
FUNDAMENTALS RATINGS
BAX vs MTD: Fundamental Ratings
BAX
MTD
OUTLOOK RATING
1..100
1318
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
923
PRICE GROWTH RATING
1..100
5958
P/E GROWTH RATING
1..100
1382
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (9) in the Medical Specialties industry is significantly better than the same rating for MTD (98). This means that BAX’s stock grew significantly faster than MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (61) in the Medical Specialties industry is somewhat better than the same rating for BAX (100). This means that MTD’s stock grew somewhat faster than BAX’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for BAX (92). This means that MTD’s stock grew significantly faster than BAX’s over the last 12 months.

MTD's Price Growth Rating (58) in the Medical Specialties industry is in the same range as BAX (59). This means that MTD’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for MTD (82). This means that BAX’s stock grew significantly faster than MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXMTD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
57%
Momentum
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
56%
MACD
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 20 days ago
52%
Bullish Trend 4 days ago
61%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 12 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
67%
Aroon
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMPB28.130.25
+0.90%
Efficient Market Portfolio Plus ETF
CVAR26.400.04
+0.17%
Cultivar ETF
SHYG43.040.01
+0.02%
iShares 0-5 Year High Yield Corp Bd ETF
EIM9.58N/A
N/A
Eaton Vance Municipal
MSD7.84-0.08
-1.01%
Morgan Stanley Emerging Markets Debt Fund

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with A. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
-0.36%
A - BAX
54%
Loosely correlated
-0.21%
RVTY - BAX
54%
Loosely correlated
-0.98%
SYK - BAX
52%
Loosely correlated
+0.81%
MTD - BAX
52%
Loosely correlated
-0.73%
STE - BAX
50%
Loosely correlated
+0.11%
More

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
-0.73%
A - MTD
85%
Closely correlated
-0.21%
RVTY - MTD
81%
Closely correlated
-0.98%
TMO - MTD
78%
Closely correlated
-0.93%
WAT - MTD
76%
Closely correlated
-0.70%
BRKR - MTD
75%
Closely correlated
-0.90%
More